Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis cells
Reproduction · 01.06.2023 · 165 (6) · 617-628
DOI: 10.1530/rep-22-0265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproduction, online erschienen am 08.05.2023. Verfasst von Arvinder Kapur und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Curcumin, Antimalarials, Endometriosis, Antineoplastic Agents. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, BLRD VA.
Abstract (Originalsprache)
In brief Developing novel therapies to cure and manage endometriosis is a major unmet need that will benefit over 180 million women worldwide. Results from the current study suggest that inhibitors of oxidative phosphorylation may serve as novel agents for the treatment of endometriosis. Abstract Current therapeutic strategies for endometriosis focus on symptom management and are not curative. Here, we provide evidence supporting the inhibition of oxidative phosphorylation (OXPHOS) as a novel treatment strategy for endometriosis. Additionally, we report an organotypic organ-on-a-chip luminal model for endometriosis. The OXPHOS inhibitors, curcumin, plumbagin, and the FDA-approved anti-malarial agent, atovaquone, were tested against the endometriosis cell line, 12Z, in conventional as well as the new organotypic model. The results suggest that all three compounds inhibit proliferation and cause cell death of the endometriotic cells by inhibiting OXPHOS and causing an increase in intracellular oxygen radicals. The oxidative stress mediated by curcumin, plumbagin, and atovaquone causes DNA double-strand breaks as indicated by the elevation of phospho-γH2Ax. Mitochondrial energetics shows a significant decrease in oxygen consumption in 12Z cells. These experiments also highlight differences in the mechanism of action as curcumin and plumbagin inhibit complex I whereas atovaquone blocks complexes I, II, and III. Real-time assessment of cells in the lumen model showed inhibition of migration in response to the test compounds. Additionally, using two-photon lifetime imaging, we demonstrate that the 12Z cells in the lumen show decreased redox ratio (NAD(P)H/FAD) and lower fluorescence lifetime of NAD(P)H in the treated cells confirming major metabolic changes in response to inhibition of mitochondrial electron transport. The robust chemotoxic responses observed with atovaquone suggest that this anti-malarial agent may be repurposed for the effective treatment of endometriosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Department of Dermatology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Morgridge Institute for Research, Madison, Wisconsin, USA.
- University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin, USA.
- Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.
ORCID-Profile: Manish S Patankar
Förderung
- NCI NIH HHS
- BLRD VA
Zitieren
APA
Kapur, A., Ayuso, J. M., Rehman, S., Kumari, S., Felder, M., Stenerson, Z., Skala, M. C., Beebe, D., Barroilhet, L., & Patankar, M. S. (2023). Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis cells. Reproduction, 165(6), 617-628. https://doi.org/10.1530/rep-22-0265
Vancouver
Kapur A, Ayuso JM, Rehman S, Kumari S, Felder M, Stenerson Z, et al. Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis cells. Reproduction. 2023;165(6):617-628. doi:10.1530/rep-22-0265
BibTeX
@article{Kapur2023,
author = {Kapur, Arvinder and Ayuso, Jose M and Rehman, Shujah and Kumari, Santosh and Felder, Mildred and Stenerson, Zach and Skala, Melisa C and Beebe, Dave and Barroilhet, Lisa and Patankar, Manish S},
title = {Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis cells},
journal = {Reproduction},
year = {2023},
volume = {165},
number = {6},
pages = {617--628},
doi = {10.1530/rep-22-0265}
}
EUVIMED